Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 and Updates Full Year 2020 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 and Updates Full Year 2020 Guidance

Emergent BioSolutions (EBS) Tops Q3 EPS by 7c

November 5, 2020 5:02 PM EST

Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $2.19, $0.07 better than the analyst estimate of $2.12. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $437.93 million.

For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.

... More